Hussman Strategic Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,500
| Closed | -$1.74M | – | 240 |
|
|
2024
Q4 | $1.74M | Buy |
+31,500
| New | +$1.74M | 0.51% | 79 |
|
|
2024
Q3 | – | Sell |
-42,000
| Closed | -$2.67M | – | 226 |
|
|
2024
Q2 | $2.67M | Buy |
42,000
+10,500
| +33% | +$669K | 0.74% | 43 |
|
|
2024
Q1 | $2.18M | Buy |
+31,500
| New | +$2.18M | 0.51% | 76 |
|
|
2021
Q3 | – | Sell |
-30,400
| Closed | -$1.07M | – | 319 |
|
|
2021
Q2 | $1.07M | Hold |
30,400
| – | – | 0.22% | 174 |
|
|
2021
Q1 | $1.1M | Hold |
30,400
| – | – | 0.23% | 170 |
|
|
2020
Q4 | $883K | Sell |
30,400
-5,100
| -14% | -$148K | 0.23% | 165 |
|
|
2020
Q3 | $1M | Hold |
35,500
| – | – | 0.26% | 153 |
|
|
2020
Q2 | $1.15M | Hold |
35,500
| – | – | 0.29% | 134 |
|
|
2020
Q1 | $1.45M | Hold |
35,500
| – | – | 0.39% | 99 |
|
|
2019
Q4 | $2.19M | Hold |
35,500
| – | – | 0.7% | 46 |
|
|
2019
Q3 | $2.59M | Buy |
35,500
+10,500
| +42% | +$765K | 0.73% | 46 |
|
|
2019
Q2 | $2.06M | Buy |
25,000
+11,500
| +85% | +$945K | 0.57% | 73 |
|
|
2019
Q1 | $952K | Sell |
13,500
-3,500
| -21% | -$247K | 0.23% | 156 |
|
|
2018
Q4 | $765K | Hold |
17,000
| – | – | 0.18% | 173 |
|
|
2018
Q3 | $961K | Buy |
+17,000
| New | +$961K | 0.28% | 126 |
|